ASIA, American Spinal Injuries Association cCPP opt , continuous optimum cerebral perfusion pressure. Using a sliding 4-hour window that is updated every minute, PRx is plotted against cerebral perfusion pressure. cCPP opt is the cerebral perfusion pressure at which PRx is minimum, i.e. the cerebral perfusion pressure that optimizes brain vascular pressure reactivity. cCPP opt applies to individual patients and is updated every minute. cSCPP opt , continuous optimum spinal cord perfusion pressure. Using a sliding 4-hour window, the SCPP of an individual patient is divided into 5 mmHg bins between 40 -120 mmHg and the mean sPRx for each bin is computed. sPRx is plotted against SCPP and cSCPP opt is the SCPP at which sPRx is minimum, i.e. the SCPP that optimizes spinal cord vascular pressure reactivity. cSCPP opt applies to an individual patient and is updated every minute. were associated with low injury site glucose, high pyruvate and high lactate. Mean SCPP deviation from cSCPP opt inversely correlated with neurological outcome at 9-12 months: ASIA grade improved in 30 % patients with <5 mmHg deviation, 10 % with 5-15 mmHg deviation and no-one with >15 mmHg deviation. We conclude that real-time computation and visualization of cSCPP opt after TSCI are feasible. cSCPP opt appears to enhance glucose utilization at the injury site and varies widely between and within patients. Our data suggest that targeting cSCPP opt after TSCI might improve neurological outcome.
INTRODUCTION
About 180,000 people suffer a traumatic spinal cord injury (TSCI) each year 1 . The consequences are catastrophic; most patients remain dependent or wheelchair-bound. Currently, the early management of TSCI patients in the neurointensive care unit is variable: In the U.K.
there are no clear blood pressure targets 2 whereas the American Association of Neurological
Surgeons' guideline of 85 -95 mmHg mean arterial pressure (MAP) has little supporting evidence 3 . To aid patient management, we developed techniques for monitoring intraspinal pressure (ISP), spinal cord perfusion pressure (SCPP), spinal pressure reactivity (sPRx) 4 , 5 and metabolism 6 from the injury site. These techniques are safe based on a recent review of 42 patients 7 . In general, the optimum spinal cord perfusion pressure (SCPP opt ), defined as the perfusion pressure that minimizes sPRx 5 , is around 90 mmHg. In our original analysis, SCPP opt was computed by pooling data from 18 patients 4, 5 . Our initial concept of a pooled SCPP opt requires revision for several reasons: First, there is now evidence that SCPP opt varies between patients 8 and that the injury site metabolic response is individualistic 9 thus targeting 90 mmHg may not benefit everyone. Second, the SCPP opt of each patient may change with time. Third, the SCPP opt can only be computed after the monitoring has been completed and is, therefore, not clinically useful. Here, we show how to compute a continuous SCPP opt (cSCPP opt ) in real-time and provide evidence that achieving this cSCPP opt may be beneficial after TSCI. is the minimum of each curve. The same method was used to obtain the individual continuous optimum spinal cord perfusion pressure (cSCPP opt ), but by using a four-hour window (unless otherwise stated) rather than the entire signal, moving forward each minute. Statistical analysis. Two-tailed t-test was used to compare metabolite level within 5 mmHg versus more than 5 mmHg from the cSCPP opt with significance at P < 0.01** and 0.005 . We used the Spearman coefficient to quantify the correlation between neurological outcome versus deviation from cSCPP opt or MAP guideline.
MATERIALS AND METHODS

RESULTS
Demographics. Table 1 Pooled SCPP opt . Using data from all 45 patients, we plotted sPRx versus ISP and sPRx versus SCPP. Figure 1A shows that as ISP increases, sPRx increases. This suggests that higher ISP correlates with more marked loss of injury site autoregulation. Figure 1B shows a U-shaped relationship between sPRx and SCPP, which suggests that the optimum SCPP is around 80 -90 mmHg. As SCPP falls below 80 mmHg or rises above 90 mmHg, injury site autoregulation progressively worsens. Since the optimum SCPP of 80 -90 mmHg was computed by pooling data from all patients, we term this pooled SCPP opt (pSCPP opt ). A major drawback of pSCPP opt is that it does not provide information about the variability of SCPP opt between patients.
Individual global SCPP opt . To test the hypothesis that SCPP opt varies between patients, we computed SCPP opt for individual patients by plotting the sPRx versus SCPP for each individual patient. We termed this the individual global (igSCPP opt ) because it only applies to an individual patient and the entire monitoring period is used. Figure 1C shows sPRx versus SCPP curve for three patients; two had a U-shaped relationship with approximately 20 mmHg difference in their igSCPP opt , whereas in one there was no correlation between sPRx and SCPP. igSCPP opt values ranged from 50 -60 mmHg in some patients up to 100 -110 mmHg in others ( Figure 1D ). In 13 11, 13 . cSCPP opt was calculated using a four-hour window, updated every minute. Histograms of continuous SCPP opt . We plotted each patient's cSCPP opt histogram (Fig. 4A ).
Distributions varied widely; some were unimodal-symmetrical with a predominant cSCPP opt peak (patient i) or a wide range of cSCPP opt values (patient ii) or bi-modal (patient iii). Left-and right-skewed unimodal distributions were also found (not shown). Fig. 4B shows the standard deviations of these distributions; in most patients, the standard deviation was high at 10 -15 mmHg and in some as high as 15 -20 mmHg. The high variability in cSCPP opt suggests that a patient's SCPP opt is dynamic and, therefore, targeting the same SCPP is inadequate. Fig. 4C shows significant positive correlation between igSCPP opt and mean cSCPP opt .
Neurological outcome. We hypothesized that larger deviation of SCPP from cSCPP opt correlates with worse neurological outcome at 9 -12 months. The data show that as the difference between SCPP and the cSCPP opt (averaged over each patient's entire monitoring period) decreases, the chance of ASIA grade improvement increases (Fig. 5A ) and the chance of having a complete neurological deficit at follow-up (ASIA A) decreases (Fig. 5B ). There are only two patients with positive mean deviation of SCPP from cSCPP opt ; thus, we do not know if hyperperfusion correlates with worse neurological outcome. There was no correlation between the American Association of Neurological Surgeons' guideline of 85 -95 mmHg MAP and the chance of ASIA grade improvement (Fig. 5C ) or the chance of having complete deficit (Fig. 5D ) at 9 -12 months.
Enhanced visualization. Displaying cSCPP opt as a line (Fig. 3) is clinically helpful, but has drawbacks. First, it fails to show the range of cSCPP opt at any one time that are associated with intact autoregulation, i.e. sPRx ≤ 0; a cSCPP opt line simplistically implies that cSCPP opt at any one time is a single value rather than a range. Second, the cSCPP opt line has gaps whenever the optimum cannot be calculated. We, therefore, used an enhanced visualization technique, recently developed to overcome these issues when monitoring in severe traumatic brain injury 11, 12 . Fig. 6 shows two monitoring periods from the same TSCI patient. The top trace shows a wide range (60 -90 mmHg) of cSCPP opt . Initially, the actual SCPP was within this range, but between 00:30 and 01:45 hours the injured cord was hypoperfused. After two days (bottom trace) the range of cSCPP opt narrowed substantially. Between 13:00 and 14:00 hours, the cSCPP opt range was narrow at around 78 mmHg, between 14:00 and 16:00 hours it was 65 -85 mmHg and, after 18:30, it narrowed again at around 85 mmHg. The enhanced visualization technique not only displays the range of cSCPP opt values at any one time, but also fills some of the gaps in the signal.
Injury site metabolism. After TSCI, injury site metabolism can be monitored using surface MD 6 . We hypothesized that small deviation of SCPP from cSCPP opt correlates with less injury site metabolic derangement. To test this, we quantified the hourly injury site metabolic state in 14 spinal cord injury patients. Figure 7 shows that hourly SCPP close to cSCPP opt is associated with low injury site glucose, high lactate and high pyruvate. As SCPP deviates from cSCPP opt by more than 5 mmHg, injury site glucose rises whereas lactate and pyruvate fall. Therefore, cSCPP opt does not minimize injury site metabolic derangement, but appears to maximize glucose utilization at the injury site. There was no correlation between deviation from cSCPP opt and glutamate, glycerol or lactate-to-pyruvate ratio (not shown). cSCPP opt was not associated with a unique metabolic profile (Supplement).
DISCUSSION
In this study, we introduced the novel concept of cSCPP opt , which is a range rather than an individual number. To guide the management of TSCI patients, we showed how cSCPP opt could be displayed in real-time using an enhanced visualization method.
Our data show that cSCPP opt varies widely between and within patients. Various reasons may explain such wide inter-patient variability: patients with more extensive microvascular damage, pre-existing hypertension or greater leukocyte infiltration at the injury site will likely require higher SCPP. The large intra-patient variability in cSCPP opt may be due to the dynamic nature of the pathological processes at the injury site e.g. changes in the numbers of infiltrating leukocytes 14 and reactive glia 15 as well as changes in injury site edema [16] [17] [18] and fever 19 20, 21 .
Is actively targeting cSCPP opt safe? Our audit of 42 patients concluded that insertion of the pressure probe and ISP monitoring for up to a week are safe 7 . However, actively increasing SCPP requires vasopressors, which may produce complications such as cardiac dysrhythmias, especially in older patients 22, 23 . We previously showed that, after TSCI, the spinal cord swells and is compressed by the dura 24 . Thus, one way to reduce vasopressor requirements is expansion duroplasty, a simple and safe surgical procedure that lowers ISP and sPRx as well as increasing SCPP 8 . Based on our experience thus far, SCPP monitoring is safe and helpful to guide management of TSCI patients 25 .
Is targeting cSCPP opt beneficial? Our MD data suggest that cSCPP opt maximizes glucose utilization by the injured cells. The Kohonen self-organizing maps 9 show that each patient's injury site metabolic response is unique. Therefore, each patient's optimal injury site metabolic profile must also be unique, which explains why cSCPP opt is not associated with a single metabolic signature (Supplement). How about neurological outcome? We found that larger deviation from cSCPP opt (hypoperfusion) is associated with worse neurological outcome at 9 -12 months, though the effect of hyperperfusion on neurological outcome could not be determined. Aries et al. 13 showed that increased deviation from cCPP opt is associated with worse neurological outcome after brain injury. These observations suggest that targeting the continuous optimum perfusion pressure may be beneficial after central nervous system injury.
Are there ways of managing spinal cord perfusion without targeting cSCPP opt ? One may follow the 85 -95 mmHg MAP guideline 3 or drain CSF with a lumbar catheter 26 . MAPoriented management may be inadequate, evident by the lack of a strong correlation between achieving the guideline and neurological outcome as shown in Fig. 6 and by others 23, 27, 28 . A major drawback of the MAP guideline is that it does not consider ISP; thus, the same MAP may hypoperfuse the injury site in one patient and hyperperfuse it in another. Also, the MAP guideline does not consider inter-and intra-patient variability in SCPP opt . Draining lumbar CSF is also likely inadequate because, at the injury site, the cord is not surrounded by CSF, but is compressed against dura 5, 8, 24, 29, 30 . Thus, CSF drainage is unlikely to reduce injury site ISP.
Ultimately, a randomized controlled trial is required to definitively determine whether interventions to achieve cSCPP opt improve neurological outcome after TSCI. Fig.,1B,,left) .,Supplementary,figure,1B,(right),shows,that,the,yellow, hexagons,are,scattered,throughout,the,map,,i.e.,having,SCPP,within,5,mmHg,of,cSCPP opt ,is, not,associated,with,a,unique,metabolic,signature.,This,finding,suggests,that,the,optimum, injury,site,metabolic,response,differs,between,patients., 
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